Review article
COVID-19 and Antihypertensive Therapy
Jure Samardžić
Full text: croatian pdf 132 Kb
page 191-196
downloads: 433
cite
APA 6th Edition
Samardžić, J. (2020). COVID-19 and Antihypertensive Therapy. Medicus, 29 (2 COVID-19), 191-191. Retrieved from https://hrcak.srce.hr/244328
MLA 8th Edition
Samardžić, Jure. "COVID-19 and Antihypertensive Therapy." Medicus, vol. 29, no. 2 COVID-19, 2020, pp. 191-191. https://hrcak.srce.hr/244328. Accessed 18 Nov. 2024.
Chicago 17th Edition
Samardžić, Jure. "COVID-19 and Antihypertensive Therapy." Medicus 29, no. 2 COVID-19 (2020): 191-191. https://hrcak.srce.hr/244328
Harvard
Samardžić, J. (2020). 'COVID-19 and Antihypertensive Therapy', Medicus, 29(2 COVID-19), pp. 191-191. Available at: https://hrcak.srce.hr/244328 (Accessed 18 November 2024)
Vancouver
Samardžić J. COVID-19 and Antihypertensive Therapy. Medicus [Internet]. 2020 [cited 2024 November 18];29(2 COVID-19):191-191. Available from: https://hrcak.srce.hr/244328
IEEE
J. Samardžić, "COVID-19 and Antihypertensive Therapy", Medicus, vol.29, no. 2 COVID-19, pp. 191-191, 2020. [Online]. Available: https://hrcak.srce.hr/244328. [Accessed: 18 November 2024]
Full text: english pdf 132 Kb
page 191-191
downloads: 1.659
cite
APA 6th Edition
Samardžić, J. (2020). COVID-19 and Antihypertensive Therapy. Medicus, 29 (2 COVID-19), 191-191. Retrieved from https://hrcak.srce.hr/244328
MLA 8th Edition
Samardžić, Jure. "COVID-19 and Antihypertensive Therapy." Medicus, vol. 29, no. 2 COVID-19, 2020, pp. 191-191. https://hrcak.srce.hr/244328. Accessed 18 Nov. 2024.
Chicago 17th Edition
Samardžić, Jure. "COVID-19 and Antihypertensive Therapy." Medicus 29, no. 2 COVID-19 (2020): 191-191. https://hrcak.srce.hr/244328
Harvard
Samardžić, J. (2020). 'COVID-19 and Antihypertensive Therapy', Medicus, 29(2 COVID-19), pp. 191-191. Available at: https://hrcak.srce.hr/244328 (Accessed 18 November 2024)
Vancouver
Samardžić J. COVID-19 and Antihypertensive Therapy. Medicus [Internet]. 2020 [cited 2024 November 18];29(2 COVID-19):191-191. Available from: https://hrcak.srce.hr/244328
IEEE
J. Samardžić, "COVID-19 and Antihypertensive Therapy", Medicus, vol.29, no. 2 COVID-19, pp. 191-191, 2020. [Online]. Available: https://hrcak.srce.hr/244328. [Accessed: 18 November 2024]
Abstract
Cardiovascular diseases (CVDs) are significantly prevalent in COVID-19 patients. According to all relevant reports and studies to date, CVDs are associated with a worse clinical course and higher mortality when combined with COVID-19. Arterial hypertension, as the most common cardiovascular entity and risk factor for premature mortality in the population, is of particular interest as a COVID-19 comorbidity due to insufficiently clarified association with COVID-19 outcomes, but also due to the potential harm of some antihypertensive drugs – specifically renin-angiotensin inhibitors, which are very often the drug of choice for treating hypertension. The presented data in this article, supported by the latest relevant literature and recommendations on the topic, will bring closer this issue and current approach to the treatment of arterial hypertension during the COVID-19 pandemic.
Keywords
COVID-19; arterial hypertension; antihypertensive drugs
Hrčak ID:
244328
URI
https://hrcak.srce.hr/244328
Publication date:
30.9.2020.
Article data in other languages:
croatian
Visits: 3.450
*
